Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells.

[1]  T. He,et al.  BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.

[2]  T. He,et al.  A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.

[3]  T. He,et al.  Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells* , 2009, Journal of Biological Chemistry.

[4]  A. Montag,et al.  Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects , 2008, Laboratory Investigation.

[5]  T. Nikawa,et al.  Effects of dimethyl sulphoxide and dexamethasone on mRNA expression of myogenesis- and muscle proteolytic system-related genes in mouse myoblastic C2C12 cells. , 2008, Journal of biochemistry.

[6]  G. Duester.  Retinoic Acid Synthesis and Signaling during Early Organogenesis , 2008, Cell.

[7]  R. Bryson-Richardson,et al.  The genetics of vertebrate myogenesis , 2008, Nature Reviews Genetics.

[8]  P. Dollé,et al.  Retinoic acid in development: towards an integrated view , 2008, Nature Reviews Genetics.

[9]  C. Kioussi,et al.  Muscle development: forming the head and trunk muscles. , 2008, Acta histochemica.

[10]  M. Rudnicki,et al.  The emerging biology of satellite cells and their therapeutic potential. , 2008, Trends in molecular medicine.

[11]  J. Berger,et al.  Retinaldehyde represses adipogenesis and diet-induced obesity , 2007, Nature Medicine.

[12]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[13]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[14]  M. Rudnicki,et al.  Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  T. He,et al.  Wnt signaling and human diseases: what are the therapeutic implications? , 2007, Laboratory Investigation.

[16]  T. He,et al.  Osteosarcoma and Osteoblastic Differentiation: A New Perspective on Oncogenesis , 2007, Clinical orthopaedics and related research.

[17]  E. Sexsmith,et al.  Differentiation of rhabdomyosarcoma cell lines using retinoic acid , 2006, Pediatric blood & cancer.

[18]  Z. Yablonka-Reuveni,et al.  The Skeletal Muscle Satellite Cell: The Stem Cell That Came in From the Cold , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[20]  G. Butler-Browne,et al.  Myogenic stem cells: regeneration and cell therapy in human skeletal muscle. , 2006, Pathologie-biologie.

[21]  P. Chambon,et al.  Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. , 2006, Annual review of pharmacology and toxicology.

[22]  A. Cumano,et al.  Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells , 2006, The Journal of cell biology.

[23]  B. Vernus,et al.  Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity. , 2005, Experimental cell research.

[24]  Claudia Eichler-Jonsson,et al.  Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid , 2005, Oncogene.

[25]  M. Hoshino,et al.  Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration , 2005, Science.

[26]  A. Mansouri,et al.  A Pax3/Pax7-dependent population of skeletal muscle progenitor cells , 2005, Nature.

[27]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[28]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[29]  Wei Jiang,et al.  Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[30]  Hongwei Cheng,et al.  Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling , 2003, Journal of cellular biochemistry.

[31]  R. Tsien,et al.  A monomeric red fluorescent protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Montag,et al.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  R. Haselbeck,et al.  Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. , 2002, Development.

[34]  H. Gronemeyer,et al.  Co-regulator recruitment and the mechanism of retinoic acid receptor synergy , 2002, Nature.

[35]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[36]  M. Rudnicki,et al.  The potential of muscle stem cells. , 2001, Developmental cell.

[37]  B. Park,et al.  Peroxisome proliferator-activated receptors: roles in tumorigenesis and chemoprevention in human cancer , 2001, Current opinion in oncology.

[38]  C. Sigman,et al.  Retinoids in chemoprevention and differentiation therapy. , 2000, Carcinogenesis.

[39]  A. Wolffe,et al.  Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. , 1999, Journal of molecular endocrinology.

[40]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[41]  J. Veerkamp,et al.  Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium , 1999, In Vitro Cellular & Developmental Biology - Animal.

[42]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[43]  A. Bonnieu,et al.  Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis , 1998, Oncogene.

[44]  R. Lotan.  Retinoids in cancer chemoprevention , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  N. Rosenthal,et al.  Regulation of a muscle-specific transgene by retinoic acid , 1995, The Journal of cell biology.

[46]  A. Bonnieu,et al.  9-cis-retinoic acid regulates the expression of the muscle determination gene Myf5. , 1993, Endocrinology.

[47]  H. Arnold,et al.  Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C , 1992, The Journal of cell biology.

[48]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.

[49]  S. Jacob,et al.  Pharmacology of DMSO. , 1986, Cryobiology.

[50]  A. Montag,et al.  Regulation of osteogenic differentiation during skeletal development. , 2008, Frontiers in bioscience : a journal and virtual library.

[51]  Ronald Breslow,et al.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug , 2007, Nature Biotechnology.

[52]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[53]  C. Emerson,et al.  Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. , 2002, Annual review of cell and developmental biology.

[54]  K. Kinzler,et al.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. , 1999, Cell.

[55]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.